SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-032259
Filing Date
2014-04-30
Accepted
2014-04-30 07:31:00
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-8308_110q.htm 10-Q 1091201
2 EX-31.1 a14-8308_1ex31d1.htm EX-31.1 12069
3 EX-31.2 a14-8308_1ex31d2.htm EX-31.2 12103
4 EX-32.1 a14-8308_1ex32d1.htm EX-32.1 7951
  Complete submission text file 0001104659-14-032259.txt   9861218

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alks-20140331.xml EX-101.INS 1216909
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20140331.xsd EX-101.SCH 96997
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alks-20140331_cal.xml EX-101.CAL 77293
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alks-20140331_def.xml EX-101.DEF 553925
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT alks-20140331_lab.xml EX-101.LAB 1846578
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20140331_pre.xml EX-101.PRE 864211
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 14795818
SIC: 2834 Pharmaceutical Preparations